نتایج جستجو برای: occult hepatitis

تعداد نتایج: 136332  

2011
Andrea Costantini Katia Marinelli Giulia Biagioni Alessia Monachetti Monica L Ferreri Luca Butini Maria Montroni Aldo Manzin Patrizia Bagnarelli

BACKGROUND Occult hepatitis B virus (HBV) infection (OBI) is characterized by HBV DNA persistence even though the pattern of serological markers indicates an otherwise resolved HBV infection. Although OBI is usually clinically silent, immunocompromised patients may experience reactivation of the liver disease. CASE PRESENTATION We report the case of an individual with human immunodeficiency v...

2016
Marija Buksa Ljiljana Peric Miro Morovic

In recent years the group of inactive carriers and that of occult hepatitis B virus infection could become a main concern due to their epidemiological and clinical significance. At present, our top priority consists of identifying, prophylaxis and monitoring of these patients undergoing immunosuppressive treatment. This report describes hepatitis B virus reactivation in the two patients in diff...

Journal: :Journal of the American Society of Nephrology 2008

Journal: :World Journal of Gastroenterology 2014

2015
Valerio Rosato Mario Masarone Ernesto Claar Marcello Persico

Occult hepatitis B virus infection (OBI) is characterised by the persistence of hepatitis B virus (HBV) genome in the liver, without any evidence of overt infection: without HBV surface antigen (HBsAg) and HBV DNA detectable in the serum, or fugacious spots of very low levels of viraemia. OBI, a possible phase in the natural history of chronic hepatitis B, is mainly due to the strong suppressio...

Journal: :Antiviral therapy 2010
Thérèse N'Dri-Yoman Xavier Anglaret Eugène Messou Alain Attia Sandrine Polneau Thomas Toni Henri Chenal Catherine Seyler Delphine Gabillard Naomi Wakasugi Serge Eholié Christine Danel

BACKGROUND In countries with high rates of chronic HBV, the World Health Organization recommends screening all HIV-infected adults for hepatitis B surface antigen (HBsAg) before initiating antiretroviral therapy (ART), and starting HIV-HBV-coinfected patients on regimens containing lamivudine (3TC) or emtricitabine (FTC) plus tenofovir disoproxil fumarate (TDF). Here, we estimated the prevalenc...

Journal: :World Journal of Gastroenterology 2009

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید